SBI Securities
WVE icon

SBI Securities’s Wave Life Sciences WVE Stock Holding History

SBI Securities’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$278 Sell
75
-32
-30% -$168 ﹤0.01% 3312
2026
Q2 		$622 Buy
107
+50
+88% +$332 ﹤0.01% 2969
2026
Q1 		$413 Sell
57
-3
-5% -$39 ﹤0.01% 2964
2025
Q4 		$1.02K Sell
60
-45
-43% -$457 ﹤0.01% 2637
2025
Q3 		$769 Buy
105
+31
+42% +$251 ﹤0.01% 2800
2025
Q2 		$481 Hold
74
– – ﹤0.01% 2985
2025
Q1 		$598 Buy
74
+5
+7% +$55 ﹤0.01% 2796
2024
Q4 		$854 Buy
+69
New +$921 ﹤0.01% 2681

Other funds holding WVE

GSK plc
GSK plc London $497M AUM 35.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
James J. Burns & Company
James J. Burns & Company Melville, New York $937M AUM 13.35% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

SBI Securities's WVE Position: Q3 2026 in Review

SBI Securities reduced its Wave Life Sciences (WVE) stake by 30% in Q3 2026, selling an estimated $168 and leaving 75 shares worth $278. The position accounts for ﹤0.01% of the portfolio, ranked #3312.

SBI Securities first reported a position in WVE in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.02K in Q4 2025. 58 funds tracked by Wall St. Rank hold WVE as of Q3 2026.

  • SBI Securities held 75 shares of Wave Life Sciences worth $278 as of Q3 2026.
  • SBI Securities sold 32 Wave Life Sciences shares in Q3 2026, an estimated $168.
  • Wave Life Sciences made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3312 holding.
  • SBI Securities first reported a position in Wave Life Sciences in Q4 2024 and has held it in 8 quarters since.
  • SBI Securities's Wave Life Sciences position peaked at $1.02K in Q4 2025.
  • 58 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.